NASDAQ: CDIO - Cardio Diagnostics Holdings, Inc.

Yield per half year: +81.15%
Sector: Healthcare

Share chart Cardio Diagnostics Holdings, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Cardio Diagnostics Holdings, Inc., компания, занимающаяся прецизионной сердечно-сосудистой медициной на основе искусственного интеллекта, разрабатывает и коммерциализирует основанные на эпигенетике клинические тесты для сердечно-сосудистых заболеваний. Он предлагает Epi+Gen CHD, трехлетний тест для оценки риска симптоматической ишемической болезни сердца (ИБС), нацеленный на события ИБС, включая сердечные приступы; и PrecisionCHD, комплексный эпигенетический анализ крови для раннего выявления ишемической болезни сердца.

more details
Компания была основана в 2017 году и имеет штаб-квартиру в Чикаго, штат Иллинойс.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA -0.000598
EV/EBITDA 0.3961
IPO date 2022-01-14
ISIN US56168P1049
Industry Biotechnology
P/BV 0.725
P/S 3282.69
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0
Сайт https://cardiodiagnosticsinc.com
Цена ао 0.895
Число акций ао 0.01269 млрд
Change price per day: -0.0306% (0.9803)
Change price per week: +0.6367% (0.9738)
Change price per month: +225.47% (0.3011)
Change price per 3 month: +347.08% (0.2192)
Change price per half year: +81.15% (0.541)
Change price per year: -60.64% (2.49)
Change price per 3 year: 0% (0.98)
Change price per 5 year: 0% (0.98)
Change price per 10 year: 0% (0.98)
Change price per year to date: -60.64% (2.49)
All parameters

Underestimation

Title Value Grade
P/S 1761.72 1
P/BV 10.16 1
P/E 0 0
EV/EBITDA -4.21 0
Total: 2.88

Efficiency

Title Value Grade
ROA, % -187.72 0
ROE, % -283.18 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1768 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 1696.32 10
Yield Ebitda, % 155.89 10
Yield EPS, % 936.68 10
Total: 10
More

Institutions Volume Share, %
Prelude Capital Management LLC 121000 0.59
Geode Capital Management, LLC 75483 0.37
Vanguard Group Inc 64022 0.31
Linden Advisors LP 45618 0.22
PNC Financial Services Group, Inc. 40500 0.2
TWO SIGMA SECURITIES, LLC 32245 0.16
State Street Corporation 20100 0.1
Renaissance Technologies, LLC 17800 0.09
Vontobel Holding Limited 12000 0.06
HRT Financial LP 11273 0.05



Head Job title Payment Year of birth
Dr. Meeshanthini V. Dogan Ph.D. Co-Founder, CEO & Director 433.9k 1989 (35 years)
Ms. Elisa Michael Luqman Esq., J.D., M.B.A. Chief Financial Officer 175.83k 1964 (60 years)
Dr. Robert A. Philibert M.D., Ph.D. Co-Founder, Chief Medical Officer & Director N/A 1962 (62 years)
Mr. Timur Dogan Ph.D. Chief Technology Officer N/A 1988 (36 years)
Ms. Khullani Abdullahi J.D. Vice President of Revenue & Strategy N/A 1984 (40 years)

Address: United States, Chicago. IL, 400 North Abderdeen Street - open in Google maps, open in Yandex maps
Website: https://cardiodiagnosticsinc.com